MDS‐associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells-Reference-Cited by-同舟云学术

MDS‐associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells

Published:2020-11-06 Issue:1 Volume:110 Page:197-205
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:J Leukocyte Bio

Author:

Pollyea Daniel A.¹,Kim Hyun Min²,Stevens Brett M.¹,Lee Frank Fang‐Yao³⁴,Harris Chelsea³⁴,Hedin Brenna R.³⁴,Knapp Jennifer R.⁴,O'Connor Brian P.³⁴⁵,Jordan Craig T.¹,Pietras Eric M.¹,Tan Aik Choon²⁶,Alper Scott³⁴⁵^ORCID

Affiliation:

1. Division of Hematology Department of Medicine University of Colorado School of Medicine Aurora Colorado USA

2. Division of Medical Oncology Department of Medicine University of Colorado School of Medicine Aurora Colorado USA

3. Department of Immunology and Genomic Medicine National Jewish Health Denver Colorado USA

4. Center for Genes Environment and Health National Jewish Health Denver Colorado USA

5. Department of Immunology and Microbiology University of Colorado School of Medicine Aurora Colorado USA

6. Department of Biostatistics and Bioinformatics Moffitt Cancer Center Tampa Florida USA

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/JLB.6AB0520-318RR

Reference39 articles.

1. Splicing-factor alterations in cancers

2. RNA splicing factors as oncoproteins and tumour suppressors

3. Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures

4. Splicing factor gene mutations in hematologic malignancies

5. Acquired Mutations That Affect Pre-mRNA Splicing in Hematologic Malignancies and Solid Tumors

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow;eLife;2024-09-05

2. Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow;eLife;2024-09-05

3. Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow;2024-08-21

4. The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms;Frontiers in Oncology;2024-07-26

5. Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow;2024-06-11